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INTRODUCTION
G laucoma is a multifactorial eye disease worldwide leading to blindness characterized by retinal ganglion cells (RGCs) degeneration [1] [2] [3] . Visual formation involves pallium pillow of brain, eyeball and visual pathway and RGCs are the unique link to transport visual information between the two organs [4] [5] [6] [7] . Furthermore, RGC axons play an important role in transporting nutrients within cycles through cell body and terminal [8] . As RGCs is axonal damage and steady loss, glaucomatous optic neuropathy progresses with gradual vision loss and visual field deficits [9] [10] . Several risk factors of glaucoma are recognized including age, family history, elevated intraocular pressure (IOP) and myopia [11] [12] . Among them abnormally elevated IOP is considered as a vital risk factor of visual function deficits [12] [13] . Clinical therapies focus on decreasing IOP to normal tension even the lower with eye drops or operations. Nevertheless these managements are not enough to prevent RGCs death [14] . In addition, eye drops have limitations such as poor compliance due to frequency and low bioavailability due to various barriers while outflow pathway blockade relapses several years after surgery [15] . Given this, gene therapy rises gradually in sorts of experiments. Several nerve growth factors (NGFs) are confirmed to benefit to cultured RGCs such as brain derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) after injury [16] [17] [18] . However these peptides with short half-life have immediate effects [19] . If recombinant viral vector is conducted, survival rate of injured RGCs in vitro and in vivo increases in a considerable time owning to sustained NGFs especially CNTF [20] [21] [22] . Recent advances elucidate CNTF stimulates gene expression, cell proliferation and neural stem cell differentiation as well as provokes neuroprotection and axons regeneration [23] [24] [25] [26] . And CNTF is reported to elicit biological effects for under several pathological conditions [25, [27] [28] . Mechanisms in relation to RGC destruction in glaucoma are currently deemed to incompetent axon transport of neurotrophic factors, reactive oxygen species (ROS), excitoxicity and chronic intermittent ischemia [29] [30] . Among above factors, the interplay between ischemia and ROS for the formation of vicious circle induces RGCs death [29, [31] [32] . Besides ROS as a direct damage element of glaucomatous neurodegeneration, it also may participate in activating signal pathway to RGCs death as a second messager [33] [34] . On the base of the pathology theory, we adopted hydrogen peroxide (H 2 O 2 ) modeling on RGC-5 cell and focused on CNTF effect on injury model.
MATERIALS AND METHODS
Retinal Ganglion Cell-5 Identification by Immunofluorescence RGC-5 cells were cultured by dulbecco's modified eagle medium (DMEM) medium supplemented with 10 mL of 10% fetal bovine serum, 1 mL of 10 5 U/L penicillin and 1 mL of 100 mg/L streptomycin in each 100 mL medium. Cells were located in 5% CO 2 incubator at 37℃ every 2d to change solution. The cell line RGC-5 at logarithmic phase was selected in the culture flask with 5% bovine serum albumin and 0.1% Triton X-100 in 0.01 mol/L phosphate buffered saline (BSAT) instead of medium at 4℃ over night. Then mixture of 5% BSAT solution and first antibody, Brn3a (Cell Signaling Technology. Inc., Boston, USA), with a proportion of 1:100 was added into flask without medium also at 4℃ over night. The following day poured away mixture, washed flask for five minutes by six times with 1×phosphate buffered saline and 0.1% Triton X-100 (PBST) and then added mixture of 5% BSAT solution and second antibody, Cy3 (Cell Signaling Technology. Inc., Boston, USA), with a proportion of 1:500 at indoor temperature for 2h. 
Real-time Polymerase Chain Reaction
While RGC-5 cells cocultured with BMSCs carrying recombinant plasmid, CNTF gene expression and neuroprotective agents such as glial cell line-derived neurotrophic factor (GDNF) and BDNF gene expression, measured by Real-time PCR at 3 and 7d versus control group without recombinant plasmid. Total RNA was extracted from cultured cells with TRIzol reagent (Shanghai Pufei Biotech Co., Ltd., Shanghai, China) according to the kit instructions. cDNA synthesis was implanted by reverse transcription by virtue of RNA PCR protocol (Promega Biotech Co., Ltd., Beijing, China). Glyceraldehyde phosphate dehydrogenase (GAPDH) was acted as a normalizing control. The several primers were as follows: CNTF: forward: 5′-CCA CCT ACA TCC CCA ATA CC-3′; reverse: 5′-GCT GAC ACT TAT GGA GAC CTT G-3′; BDNF: forward: 5′-GGT TAT TTC ATA CTT CGG TTG C-3′; reverse: 5′-CCC ATT CAC GCT CTC CAG-3′; GDNF: forward: 5′-CGA TAT TGT AGC GGT TCC TGT-3′; reverse: 5′-CCT TGT CAC TTG TTA GCC TTC T-3′; GAPDH: forward: 5′-TTC AAC GGC ACA GTC AAG G-3′; reverse: 5′-CTC AGC ACC AGC ATC ACC T-3′ (Genechem Co., Ltd., Shanghai, China). The PCR reaction system was performed in a volume of 25 μL using the SYBR Master Mix (Toyobo Co., Ltd., Shanghai, China) on the MX3000p real-time PCR instrument (Agilent Technologies Inc., California, USA). In SYBR Green PCRs the melting curve was in the 60℃-95℃ range to evaluate amplification products. Relative quantification of gene expression was performed using the 2 -ΔΔCt method.
Detection of Cell Viability by Application of Ciliary
Neurotrophic Factor by MTT Assay To explore CNTF efficacy to H 2 O 2 injury model of RGC-5, each groups were measured by MTT assay. Experimental groups including: pGC-FU-CNTF group, 50 ng/mL CNTF group, 100 ng/mL CNTF Figure 4B ). Since BMSCs enable to secret various growth factors, as carriers they trigger upregulation of BDNF, GDNF expression and so on. Compared with control group, there was significant upregulation of BDNF gene expression in BMSCs additional groups at 7d (332.29±146.23, P<0.05) while GDNF gene expression was not significant in any experimental groups ( Figure 4C, 4D) . And elevated levels of BDNF expression was in accord with prolonged time.
Two drug administrations to intervene injured RGC-5 cells

Ciliary Neurotrophic Factor Effect of Two Ways Against Hydrogen Peroxide Induced Retinal Ganglion Cell-5
Model Two ways of CNTF as follow one was addition of CNTF in the culture medium directly and the other one was recombinant plasmid carrying CNTF gene while they were adopted with its own advantages such as certain dosage and continuous pharmic infusion. As shown in Figure 3 , 125 µmol/L H 2 O 2 alone was toxic to the cells causing at most 30.24% cell death while the effects of CNTF differentiated to some extent on resistance to oxidative damage. In the first day the survival rate of RGC-5 cells with additional CNTF had no significant difference among every CNTF concentration groups. When RGC-5 cells cultured in second day, the low level of CNTF groups (50 and 100 ng/mL) had statistic difference with high concentration groups (150, 200 and 250 ng/mL) in cell viability. However there were no difference in every high concentration groups. And in third day the results were same as the previous day. Only 50 ng/mL group had difference with the groups of the other concentrations in fourth day. While analyses from all groups revealed no difference five days later ( Figure 5 ). Therefore we chose 150 ng/mL to intervene for three days and this method of administration would be compared with the approach by recombinant lentivirus. Both 150 ng/mL CNTF and recombinant plasmid made a difference on resistance to oxidative damage and on protection of RGCs. As comparison with the optimal concentration group of 24.57% cell death, recombinant plasmid group reduced cell death to 19.23% with no statistically significant differences (P>0.05; Figure 6 ). DISCUSSION RGCs, as a precious medium to visual formation, reduce in glaucoma and there is no available remission as far. In many researches, NGF are confirmed to protective factors for injured RGCs as well as our study demonstrated that CNTF had a positive effect on RGC-5 cell death induced by H 2 O 2 . Taken together, the acknowledged mechanisms of RGCs death are as follows: 1) neurotrophic factors deficiency due to invalid axonal transport; 2) glutamic toxicity; 3) free radical concentration; 4) nitric oxide toxicity; 5) apoptosis [35] . H 2 O 2 , one member of ROS as same as free radical, was used to make model in the study to cause RGC-5 loss by oxidative stress. CNTF function in neuron via heterotrimeric complex that is ciliary neurotrophic factor receptor-α (CNTFRα) the only one part anchored at surface membrane, gp130 and leukemia inhibitory factor-β (LIFRβ) [36] . CNTF binds CNTFRα at the first step then does the heterodimer of gp130 and LIFRβ [37] [38] [39] . Whereas RGCs are unable to secrete proteins, the choice of BMSCs as medium was because not only it had the stable biological characteristics but also could secrete CNTF itself. Based on the influence of CNTF on cell model we could select the optimal concentration which was a hint for in vivo experiments by intravitreal injection or implanted intraocular secretion apparatus. In general, CNTF is an effective neurotrophin for RGCs through sorts of signal pathways acting on recipient cells. Special process about how CNTF plays a pivotal role is still an open question. 
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